NCT07297277 Evaluating the Level of Agreement Between AAMI/ESH/ISO Universal Standard Requirements and the HUAWEI D2 Watch-Type Wrist Blood Pressure Monitor
| NCT ID | NCT07297277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northumbria University |
| Condition | Blood Pressure Monitoring |
| Study Type | OBSERVATIONAL |
| Enrollment | 85 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 85 participants in total. It began in 2025-07-15 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Getting an accurate blood pressure (BP) reading is essential for diagnosing high blood pressure and managing it effectively. High blood pressure is a major health problem, causing about 9.4 million deaths worldwide each year. More people need to monitor their BP at home, so there is greater demand for easy-to-use devices. Traditional BP monitors with arm cuffs can be bulky, uncomfortable, and awkward to use. Modern technology has made it possible to measure BP using wearable devices like smartwatches. HUAWEI has developed a wrist watch that can measure BP and has been tested to meet international standards. The watch passed these tests and was approved for people to use at home to check their own BP. However, the HUAWEI watch was only tested on people in China and the investigators need to know if it works for people from other countries and ethnic backgrounds.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years * Written informed consent provided Exclusion Criteria: * Cardiac Arrythmias * Peripheral Arterial Disease * Known Heart Disease * Pregnancy * Diagnosis of Secondary Hypertension
Contact & Investigator
Gabriel Cucato, PhD
PRINCIPAL INVESTIGATOR
Northumbria University
Frequently Asked Questions
Who can join the NCT07297277 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure Monitoring. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07297277 currently recruiting?
Yes, NCT07297277 is actively recruiting participants. Contact the research team at helen.llewellyn@northumbria.ac.uk for enrollment information.
Where is the NCT07297277 trial being conducted?
This trial is being conducted at Newcastle upon Tyne, United Kingdom.
Who is sponsoring the NCT07297277 clinical trial?
NCT07297277 is sponsored by Northumbria University. The principal investigator is Gabriel Cucato, PhD at Northumbria University. The trial plans to enroll 85 participants.